English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Vascular access ports were developed to overcome many of the problems associated with limited peripheral access, combined with the need for frequent venipuncture, in oncology patients receiving long-term, intensive therapy. Since their introduction in 1983, implantable vascular access ports have become a standard of use in the treatment of oncology diseases. Currently, over 200,000 ports are implanted in the United States each year and their popularity is increasing. Vascular access ports have proven to be very beneficial in overcoming the need for frequent venipuncture in the treatment of long-term venous therapies. However, a review of the literature does reveal many problems associated with their use. The most common complications associated with the use of vascular access ports are occlusions and thrombus formations. A Randomized, Prospective Trial of Conventional Vascular Ports vs. The Vortex“Clear-Flow” Reservoir Port in Adult Oncology Patients

A randomized, prospective trial of conventional vascular ports vs. the vortex “clear-flow” reservoir port in adult oncology patients